Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ALLOB in Lumbar Spinal Fusion
NCT02205138Phase 2Completed
- Sponsor
- BioSenic
- Start
- Oct 2014
- Primary completion
- Feb 2019
- Modality
- Stem Cell Therapies
- Countries
- 1
01
Overview
A Phase 2 trial of allogeneic osteoblastic cells in degenerative disc disease (DDD), sponsored by BioSenic. Started Oct 2014; status: completed.
02
Drugs
allogeneic osteoblastic cells
03
Conditions
degenerative disc disease (DDD)
Beyond the preview
Go deeper on NCT02205138.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02205138.